A flagship programme developed by Lancaster University in partnership with the NHS aims to open up medicine as a career ...

Hurricane Milton churned Wednesday toward a potentially catastrophic collision along the west coast of Florida, two weeks ...

Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.

Developer and investor Sama Investment Group has submitted plans for the transformation of 1 Lancaster Circus in Birmingham.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Solar panels and infrastructure have been approved for land just south of Burrow Beck at Bailrigg Lane in Lancaster ...

Researchers make promising breakthrough in Alzheimer’s drug development: Lancaster Monday, October 7, 2024, 11:00 Hrs [IST] An international team of researchers led by Lancaster ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

So, here all the UK unis that came in the top 200 unis in the world in Times Higher Education’s World University Rankings, ...